690 related articles for article (PubMed ID: 33542062)
1. Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic.
Reynolds-Wright JJ; Johnstone A; McCabe K; Evans E; Cameron S
BMJ Sex Reprod Health; 2021 Oct; 47(4):246-251. PubMed ID: 33542062
[TBL] [Abstract][Full Text] [Related]
2. Adherence to treatment and prevalence of side effects when medical abortion is delivered via telemedicine: a prospective observational cohort study during COVID-19.
Reynolds-Wright JJ; Johnstone A; McCabe K; Evans E; Cameron S
BMJ Sex Reprod Health; 2022 Jul; 48(3):185-192. PubMed ID: 34711647
[TBL] [Abstract][Full Text] [Related]
3. Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation.
Boydell N; Reynolds-Wright JJ; Cameron ST; Harden J
BJOG; 2021 Oct; 128(11):1752-1761. PubMed ID: 34138505
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study.
Aiken A; Lohr PA; Lord J; Ghosh N; Starling J
BJOG; 2021 Aug; 128(9):1464-1474. PubMed ID: 33605016
[TBL] [Abstract][Full Text] [Related]
5. Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
Meurice ME; Whitehouse KC; Blaylock R; Chang JJ; Lohr PA
Contraception; 2021 Jul; 104(1):61-66. PubMed ID: 33974918
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls.
Moseson H; Jayaweera R; Egwuatu I; Grosso B; Kristianingrum IA; Nmezi S; Zurbriggen R; Motana R; Bercu C; Carbone S; Gerdts C
Lancet Glob Health; 2022 Jan; 10(1):e105-e113. PubMed ID: 34801131
[TBL] [Abstract][Full Text] [Related]
7. A qualitative study of abortion care providers' perspectives on telemedicine medical abortion provision in the context of COVID-19.
Reynolds-Wright JJ; Boydell N; Cameron S; Harden J
BMJ Sex Reprod Health; 2022 Jul; 48(3):199-204. PubMed ID: 34848554
[TBL] [Abstract][Full Text] [Related]
8. UTAH: Using Telemedicine to improve early medical Abortion at Home: a protocol for a randomised controlled trial comparing face-to-face with telephone consultations for women seeking early medical abortion.
Reynolds-Wright JJ; Norrie J; Cameron ST
BMJ Open; 2021 Jun; 11(6):e046628. PubMed ID: 34135047
[TBL] [Abstract][Full Text] [Related]
9. Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.
Schmidt-Hansen M; Cameron S; Lohr PA; Hasler E
Am J Obstet Gynecol; 2020 Jun; 222(6):551-563.e13. PubMed ID: 31715147
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of no-test medical abortion provided via telemedicine during Covid-19: analysis of patient-reported outcomes.
Porter Erlank C; Lord J; Church K
BMJ Sex Reprod Health; 2021 Oct; 47(4):261-268. PubMed ID: 33602718
[TBL] [Abstract][Full Text] [Related]
11. Self-reported contraceptive use and satisfaction among women accessing telemedicine medical abortion at the onset of the COVID-19 pandemic at 3-6-month follow-up.
Vianello M; Reynolds-Wright JJ; Cameron S
BMJ Sex Reprod Health; 2023 Jan; 49(1):21-26. PubMed ID: 35777953
[TBL] [Abstract][Full Text] [Related]
12. Expulsion at home for early medical abortion: A systematic review with meta-analyses.
Schmidt-Hansen M; Pandey A; Lohr PA; Nevill M; Taylor P; Hasler E; Cameron S
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):727-735. PubMed ID: 33063314
[TBL] [Abstract][Full Text] [Related]
13. Abortion services during the COVID-19 pandemic: a systematic review.
Qaderi K; Khodavirdilou R; Kalhor M; Behbahani BM; Keshavarz M; Bashtian MH; Dabir M; Irani M; Manouchehri E; Farahani MF; Mallah MA; Shamsabadi A
Reprod Health; 2023 Apr; 20(1):61. PubMed ID: 37055839
[TBL] [Abstract][Full Text] [Related]
14. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
Kerestes C; Murayama S; Tyson J; Natavio M; Seamon E; Raidoo S; Lacar L; Bowen E; Soon R; Platais I; Kaneshiro B; Stowers P
Contraception; 2021 Jul; 104(1):49-53. PubMed ID: 33789080
[TBL] [Abstract][Full Text] [Related]
15. Uptake of long-acting reversible contraception after telemedicine delivered abortion during Covid-19.
Dixon A; Reynolds-Wright JJ; Cameron ST
Eur J Contracept Reprod Health Care; 2022 Aug; 27(4):284-288. PubMed ID: 35713651
[TBL] [Abstract][Full Text] [Related]
16. Provision of medical abortion using telemedicine in Brazil.
Gomperts R; van der Vleuten K; Jelinska K; da Costa CV; Gemzell-Danielsson K; Kleiverda G
Contraception; 2014 Feb; 89(2):129-33. PubMed ID: 24314910
[TBL] [Abstract][Full Text] [Related]
17. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
18. Why women choose self-managed telemedicine abortion in the Netherlands during the COVID-19 pandemic: a national mixed methods study.
Cui N; Gemzell-Danielsson K; Gomperts R
BMJ Sex Reprod Health; 2023 Apr; 49(2):105-111. PubMed ID: 36410763
[TBL] [Abstract][Full Text] [Related]
19. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
[TBL] [Abstract][Full Text] [Related]
20. Should COVID-specific arrangements for abortion continue? The views of women experiencing abortion in Britain during the pandemic.
Lohr PA; Lewandowska M; Meiksin R; Salaria N; Cameron S; Scott RH; Reiter J; Palmer MJ; French RS; Wellings K
BMJ Sex Reprod Health; 2022 Oct; 48(4):288-294. PubMed ID: 35459711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
